Advertisement

Silver-embedded screens in the intensive care unit. A new tool to control multi-drug resistant bacterial cross-transmission

  • J. Ruiz
  • P. RamirezEmail author
  • E. Villarreal
  • M. Gordon
  • S. Cuesta
  • M. Piñol
  • J. Frasquet
  • Á. Castellanos
Original Article

Abstract

The purpose of this study was to assess the effectiveness of silver-embedded surfaces (BactiBlock®) to prevent surface colonization by multi-resistant bacteria (MRB) and to reduce the incidence of MRB colonization and infection in patients admitted to an intensive care unit (ICU). A 6-month prospective observational study in a 24-bed mixed ICU divided into two identical subunits (12 beds each) was designed. Seven solid mobile screens were placed in one of the subunits while in the other cloth screens remained. Solid screens were constructed with high-density polyethylene embedded in Bactiblock®. To evaluate the effectiveness of screens coated with Bactiblock®, number of MRB isolates on screens were compared for 6 months. Likewise, numbers of new patients and ICU-stays with MRB colonization in the two subunits were compared. One hundred forty screen samples were collected in 10-point prevalent days. MRB were detected on 28 (20.0%) samples. Over the 70 samples taken on cloth folding screens, MRB were detected in 25 (35.7%), while only 3 (4.3%) of the 70 samples taken on Bactiblock® screens were positive for MRB (p < 0.001). The unit with Bactiblock® screens presented fewer number of ICU stays with MRB colonization (27.8% vs 47.1%; p < 0.001). No significant differences were found in the global incidence of MRB nosocomial infection. The presence of Bactiblock® embedded in solid folding screens avoided MRB surface colonization and reduced MRB transmission to patients admitted to critical care units, proving to be an useful tool in the control of MRB.

Keywords

Intensive Care Unit Nosocomial Infection Intensive Care Unit Stay Acinetobacter Baumannii Critical Care Unit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The Hospital La Fe Bioethical Committee approved this study.

Informed consent

Not applicable.

References

  1. 1.
    Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12CrossRefPubMedGoogle Scholar
  2. 2.
    Antimicrobial resistance interactive database (EARS-Net). Available at: http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/ database/Pages/database.aspx. Accessed 12 December 2015
  3. 3.
    National Antimicrobial Resistance Monitoring System for Enteric Bacteria Report. CDC. Available at: http://www.cdc.gov/narms/reports/index.html. Accessed 10 December 2015
  4. 4.
    The bacterial challenge: time to react. ECDC/EMEA Technical report. 2009. Available at: http://www.ecdc.europa.eu/en/publications/Publications. Accessed 10 December 2015
  5. 5.
    Page K, Wilson M, Parkin IP (2009) Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital acquired-infections. J Mater Chem 19:3819–3831CrossRefGoogle Scholar
  6. 6.
    Balm MN, Salmon S, Jureen R, Teo C, Mahdi R, Seetoh T, Teo JT, Lin RT, Fisher DA (2013) Bad design, bad practices, bad bugs: frustrations in controlling an outbreak of Elizabethkingia meningoseptica in intensive care units. J Hosp Infect 85:134–140CrossRefPubMedGoogle Scholar
  7. 7.
    Wilson APR, Smyth D, Moore G, Singleton J, Jackson R, Gant V, Jeanes A, Shaw S, James E, Cooper B, Kafatos G, Cookson B, Singer M, Bellingan G (2011) The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med 39:651–658CrossRefPubMedGoogle Scholar
  8. 8.
    Tokmaji G, Vermeulen H, Müller MC, Kwakman PH, Schultz MJ, Zaat SA (2015) Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients. Cochrane Database Syst Rev 8:CD009201Google Scholar
  9. 9.
    Brennan SA, Ní Fhoghlú C, Devitt BM, O’Mahony FJ, Brabazon D, Walsh A (2015) Silver nanoparticles and their orthopaedic applications. Bone Joint J 97B:582–589CrossRefGoogle Scholar
  10. 10.
    Marx DE, Barillo DJ (2014) Silver in medicine: the basic science. Burns J 40:S9–18CrossRefGoogle Scholar
  11. 11.
    WHO (2009) WHO Guidelines on hand hygiene in health care. 2009. WHO, Geneva. Available at: http://www.who.int/gpsc/5may/tools/en/. Accessed 15 December 2015
  12. 12.
    Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281CrossRefPubMedGoogle Scholar
  13. 13.
    Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:1105–1113CrossRefGoogle Scholar
  14. 14.
    Papazian L, Thomas P, Garbe L, Guignon I, Thirion X, Charrel J, Bollet C, Fuentes P, Gouin F (1995) Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 152:1982–1991CrossRefPubMedGoogle Scholar
  15. 15.
    Ben-Abraham R, Keller N, Szold O, Vardi A, Weinberg M, Barzilay Z, Paret G (2002) Do isolation rooms reduce the rate of nosocomial infections in the pediatric intensive care unit? J Crit Care 17:176–180CrossRefPubMedGoogle Scholar
  16. 16.
    Ucgun I, Dagli CE, Kiremitci A, Yildirim H, Ak G, Aslan S (2013) Effects of isolation rooms on the prevalence of hospital acquired pneumonia in a respiratory ICU. Eur Rev Med Pharmacol Sci 17:S2–S8Google Scholar
  17. 17.
    Russotto V, Cortegiani A, Gregoretti C, Raineri SM, Giarratano A (2016) ICU-acquired infections: it is not only about the number of patients per room. J Crit Care 2016:30–34CrossRefGoogle Scholar
  18. 18.
    Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A (2011) Risk of acquiring multidrug-resistant gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 17:1201–8CrossRefPubMedGoogle Scholar
  19. 19.
    Yu F, Ying Q, Chen C, Ding B, Liu Y, Lu Y, Qin Z, Parsons C, Salgado C, Qu D, Pan J, Wang L (2012) Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China. J Med Microbiol 61:984–989CrossRefPubMedGoogle Scholar
  20. 20.
    Lister DM, Kotsanas D, Ballard SA, Howden BP, Carse E, Tan K, Scott C, Gillespie EE, Mahony AA, Doherty R, Korman TM, Johnson PD, Stuart RL (2015) Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service. Am J Infect Control 43:1061–1065CrossRefPubMedGoogle Scholar
  21. 21.
    Obeidat N, Jawdat F, Al-Bakri AG, Shehabi AA (2014) Major biologic characteristics of Acinetobacter baumannii isolates from hospital environmental and patients’ respiratory tract sources. Am J Infect Control 42:401–404CrossRefPubMedGoogle Scholar
  22. 22.
    Cosgrove SE (2006) The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 42:S82–S89CrossRefPubMedGoogle Scholar
  23. 23.
    Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM (2006) Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol 27:1068–1075CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  • J. Ruiz
    • 1
  • P. Ramirez
    • 1
    Email author
  • E. Villarreal
    • 1
  • M. Gordon
    • 1
  • S. Cuesta
    • 1
  • M. Piñol
    • 1
  • J. Frasquet
    • 1
  • Á. Castellanos
    • 1
  1. 1.Hospital Universitario y Politécnico la FeValenciaSpain

Personalised recommendations